Gerald Kleymann
Impact in
- Epidemiology top 5%
- Herpesvirus Infections and Treatments
-
- HIV/AIDS drug development and treatment
Papers in
- Epidemiology 22
- Herpesvirus Infections and Treatments 22
-
- Psoriasis: Treatment and Pathogenesis 4
- Co-authors
- Helga Rübsamen‐Waigmann (3 shared papers)Hartmut Michel (4 shared papers)Christian Ostermeier (3 shared papers)Ulrich A. K. Betz (1 shared paper)Rüdiger Fischer (1 shared paper)Martin Hendrix (1 shared paper)Christian Gege (13 shared papers)Hartwig Müller (1 shared paper)
- Journals
- Antiviral Research (4 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Expert Opinion on Therapeutic Patents (4 papers)Expert Opinion on Investigational Drugs (3 papers)European Journal of Biochemistry (2 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Gerald Kleymann
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Epidemiology 591
- Infectious Diseases 88
- Pharmacology 66
- Organic Chemistry 140
- Structural Biology 8
Countries citing papers authored by Gerald Kleymann
This map shows the geographic impact of Gerald Kleymann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Kleymann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Kleymann more than expected).
Fields of papers citing papers by Gerald Kleymann
This network shows the impact of papers produced by Gerald Kleymann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Kleymann. The network helps show where Gerald Kleymann may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Kleymann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 284 | |
| 2 | 2003 | 135 | |
| 3 | 2002 | 119 | |
| 4 | 1995 | 74 | |
| 5 | 2005 | 65 | |
| 6 | 2003 | 54 | |
| 7 | 2007 | 44 | |
| 8 | 2021 | 44 | |
| 9 | 1993 | 43 | |
| 10 | 2008 | 40 | |
| 11 | 1996 | 39 | |
| 12 | New antiviral drugs that target herpesvirus helicase primase enzymes. | 2003 | 36 |
| 13 | 2004 | 30 | |
| 14 | 2008 | 23 | |
| 15 | 2004 | 22 | |
| 16 | 1993 | 20 | |
| 17 | 2011 | 20 | |
| 18 | 2018 | 19 | |
| 19 | 1995 | 18 | |
| 20 | 2011 | 17 |
About Gerald Kleymann
Gerald Kleymann is a scholar working on Epidemiology, Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Structural Biology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (22 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Antifungal resistance and susceptibility (2 papers), Receptor Mechanisms and Signaling (1 paper), Structural and Chemical Analysis of Organic and Inorganic Compounds (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Viral Infections and Outbreaks Research (1 paper). The work is most often cited by research in Epidemiology (591 citations), Infectious Diseases (88 citations), Pharmacology (66 citations), Organic Chemistry (140 citations) and Structural Biology (8 citations). Gerald Kleymann has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Helga Rübsamen‐Waigmann, Hartmut Michel, Christian Ostermeier, Ulrich A. K. Betz, Rüdiger Fischer, Martin Hendrix, Christian Gege, Hartwig Müller, Veronika Hellwig and Anke Mayer‐Bartschmid. Their work appears in journals such as Antiviral Research, Bioorganic & Medicinal Chemistry Letters, Expert Opinion on Therapeutic Patents, Expert Opinion on Investigational Drugs and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.